Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism

被引:60
作者
Ramos, JW [1 ]
Hughes, PE
Renshaw, MW
Schwartz, MA
Formstecher, E
Chneiweiss, H
Ginsberg, MH
机构
[1] Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
[2] Coll France, INSERM, Chaire Neuropharmacol, U114, F-75231 Paris, France
关键词
D O I
10.1091/mbc.11.9.2863
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PEA-15 is a small, death effector-domain (DED)-containing protein that was recently demonstrated to inhibit tumor necrosis factor-alpha-induced apoptosis and to reverse the inhibition of integrin activation due to H-Ras. This led us to investigate the involvement of PEA-15 in Ras signaling. Surprisingly, PEA-15 activates the extracellular signal receptor-activated kinase (ERK) mitogen-activated protein kinase pathway in a Ras-dependent manner. PEA-15 expression in Chinese hamster ovary cells resulted in an increased mitogen-activated protein kinase kinase and ERK activity. Furthermore; PEA-15 expression leads to an increase in Pas guanosine 5'-triphosphate loading. PEA-15 bypasses the anchorage dependence of ERK activation. Finally, the effects of PEA-15 on integrin signaling are separate from those on ERK activation. Heretofore, all known DEDs functioned in the regulation of apoptosis. in contrast, the DED of PEA-15 is essential for its capacity to activate ERK. The ability of PEA-15 to simultaneously inhibit apoptosis and potentiate Ras-to-Erk signaling may be of importance for oncogenic processes.
引用
收藏
页码:2863 / 2872
页数:10
相关论文
共 57 条
[1]   LOW-MOLECULAR-WEIGHT, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS [J].
ALIG, L ;
EDENHOFER, A ;
HADVARY, P ;
HURZELER, M ;
KNOPP, D ;
MULLER, M ;
STEINER, B ;
TRZECIAK, A ;
WELLER, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4393-4407
[2]  
ARAUJO H, 1993, J BIOL CHEM, V268, P5911
[3]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[4]  
BAGRODIA S, 1995, J BIOL CHEM, V270, P27995
[5]   A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro [J].
Baker, EK ;
Tozer, EC ;
Pfaff, M ;
Shattil, SJ ;
Loftus, JC ;
Ginsberg, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1973-1978
[6]   IDENTIFICATION OF A MAMMARY TRANSFORMING GENE (MAT1) ASSOCIATED WITH MOUSE MAMMARY CARCINOGENESIS [J].
BERA, TK ;
GUZMAN, RC ;
MIYAMOTO, S ;
PANDA, DK ;
SASAKI, M ;
HANYU, K ;
ENAMI, J ;
NANDI, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) :9789-9793
[7]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[8]   A NOVEL PROTEIN THAT INTERACTS WITH THE DEATH DOMAIN OF FAS/APO1 CONTAINS A SEQUENCE MOTIF RELATED TO THE DEATH DOMAIN [J].
BOLDIN, MP ;
VARFOLOMEEV, EE ;
PANCER, Z ;
METT, IL ;
CAMONIS, JH ;
WALLACH, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :7795-7798
[9]   Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death [J].
Boldin, MP ;
Goncharov, TM ;
Goltsev, YV ;
Wallach, D .
CELL, 1996, 85 (06) :803-815
[10]  
BOS JL, 1997, BIOCHIM BIOPHYS ACTA, V1333, P19